AACR Awards 34 Students the AACR-Thomas J. Bardos Science Education Award for Undergraduate Students
CHICAGO — The American Association for Cancer Research will recognize 34 recipients of the AACR-Thomas J. Bardos Science Education Award for Undergraduate Students at the AACR Annual Meeting 2012, held here March 31 – April 4.
The primary purpose of the Bardos award is to inspire science students at the undergraduate level to enter the field of cancer research.
The AACR is committed to promoting the education and training of the next generation of dedicated scientists, and to facilitating and nurturing their careers in cancer research or cancer-related biomedical science. Since its founding in 1997, AACR Science Education Awards have been supported by generous annual contributions from a distinguished member of the AACR, Dr. Thomas J. Bardos, Ph.D. His contributions are subsequently matched by those of the AACR. The National Cancer Institute Center to Reduce Cancer Health Disparities generously provides additional funding to support the participation of underrepresented minority students.
The recipients of the 2011-2012 AACR-Thomas J. Bardos Science Education Award for Undergraduate Students include:
- Jeff Chen, University of California Davis, Davis, Calif.;
- Benjamin W. Dulken, University of Washington, Seattle, Wash.
Abstract #4770. Delivery of doxorubicin to multi-drug resistant murine xenografts via drug-loaded micelles formed from mixtures of amphiphilic triblock copolymers;
- Aurian P. Garcia-Gonzalez, University of Puerto Rico-Rio Piedras, San Juan, Puerto Rico;
- Allison Gomez, University of California, San Diego, San Diego, Calif.;
- Kelsey Gray, Ohio State University, Columbus, Ohio
Abstract #103. DCPS as a cutaneous squamous cell carcinoma susceptibility gene;
- Akash Gupta, University of Louisville, Louisville, Ky.;
- Nisan M. Hubbard, Virginia Commonwealth University, Richmond, Va.;
- Thomas M. Kaffenberger, Ohio State University Medical Center, Columbus, Ohio;
- Steve L. Lu, The University of Texas, Austin, Texas;
- Ashwathi S. Mohan, Texas A&M University, College Station, Texas;
- Melony A. Ochieng, North Carolina Central University, Durham, N.C.;
- Emily E. Ortega, Johns Hopkins University, Baltimore, Md.;
- Daniel W. Sharp, Brigham Young University, Provo, Utah;
- Daniel C. Sotelo, University of Arizona, Tucson, Ariz.;
- Ken Tanaka, International Christian University, Tokyo, Japan;
- Christopher A. Walker, University of Georgia, Athens, Ga.; and
- Lian Zhu, University of Michigan, Ann Arbor, Mich.
Abstract #2139. RhoC is a determinant of metastatic potential and affects the abundance of breast cancer stem cells.
The recipients of the 2012-2013 AACR-Thomas J. Bardos Science Education Award for Undergraduate Students include:
- Grace C. Blitzer, University of Wisconsin-Madison, Madison, Wis.
Abstract #2352. Molecular profiles of head and neck cancer tumorgrafts;
- Sara K. Coulup, University of Colorado Boulder, Boulder, Colo.
Abstract #4745. Multivalent dendrimeric peptides as new biomarker probes for the detection of cancer metastasis;
- Victoria E. Deneke, Indiana University School of Medicine-South Bend, Notre Dame, Ind.
Abstract #2183. Determining the functional roles of the specific isoforms of ARID3B from cellular localizations;
- Lois M. Dodson, University of Michigan, Ann Arbor, Mich.;
- Jerry Fong, Washington University, St. Louis, Mo.
Abstract #1457. Valproic acid enhances radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells;
- Wenji Guo, University of Illinois at Chicago, Chicago, Ill.
Abstract #4322. Iron increases the invasiveness of prostate cancer cells in vitro: Mechanisms and inhibition by the antioxidant ebselen;
- Selena Kuo, University of California, San Diego, La Jolla, Calif.
Abstract #3378. Metformin protects head and neck cancer stem cells against DNA damage-induced apoptosis;
- Russell J. Ledet, Southern University and A&M College, Baton Rouge, La.
Abstract #5735. Synthesis and characterization of PEG-ylated porphyrins for targeting the epidermal growth factor receptor in colorectal cancer detection;
- Daniel O. Macaulay, Prairie View A&M University, Prairie View, Texas
- Abstract #4773. Synergistic effects of chitosan and docosahexanoic acid on osteopontin expression and secretion in an ovarian cancer cell line, SKOV-3
Abstract #3931. Progesterone and estrogen affect the expression and secretion of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in RL95-2 cells, an endometrial cancer cell line;
- Clarissa R. Martins, University of Nevada, Reno, Nev.
Abstract #5440. Upregulation of prostaglandin E2 and TGF-alpha by linoleic acid enhances pro-oncogenic signaling in models of human lung and breast cancer;
- Gael R. Nicolas, University of South Florida, Tampa, Fla.
Abstract #2897. Preferential drug delivery to cancer cells than to normal cells by using the Niosome-Chitosan Thermo-Responsive Double Package System (NCTR-DPS);
- Elham Rahimy, University of California, San Diego, San Diego, Calif.
Abstract #422. Nanog promotes PI3K/Akt and mTOR-mediated invasion in head and neck squamous cell carcinoma;
- John L. Robinson, University of South Florida, Tampa, Fla;
- Connie R. Shi, University of Michigan, Ann Arbor, Mich.
- Abstract #5622. Effect of novel RhoC inhibitor on breast cancer progression and metastasis in vivo;
- Ronald F. Siebenaler, Ohio State University, Columbus, Ohio;
- Helen Unger, Yeshiva University, New York, N.Y.
Abstract #2253. New targets of mTORC1 pathway in ER-positive cells; and
- Jimmy N. Vo, University of Arkansas, Fayetteville, Ark.
Abstract #1535. Intratumoral chitosan/interleukin-12 immunotherapy reduces breast cancer metastasis.
Press registration for the AACR Annual Meeting 2012 is free to qualified journalists and public information officers: www.aacr.org/PressRegistration.
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research. The AACR actively communicates with legislators and policymakers about the value of cancer research and of related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.
In Chicago, March 31 – April 4: